Synthesis, β-Glucuronidase Inhibition, and Molecular Docking Studies of 1,2,4-Triazole Hydrazones

QR Code

Synthesis, β-Glucuronidase Inhibition, and Molecular Docking Studies of 1,2,4-Triazole Hydrazones

A series of 1,2,4-triazole hydrazones 1–25 has been synthesized and characterized using different spectroscopic techniques including FT-IR, 1H-NMR, and ESI MS spectrometry. The synthetic derivatives were evaluated for their β-glucuronidase enzyme inhibition properties. Among them, 17 compounds demon...

Full description

Bibliographic Details
Published in:	Journal of the Iranian Chemical Society
Main Author:	Jamil W.; Kumari D.; Taha M.; Khan M.N.; Baharudin M.S.; Ali M.; Kanwal M.; Lashari M.S.; Khan K.M.
Format:	Article
Language:	English
Published:	Springer Verlag 2018
Online Access:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053018316&doi=10.1007%2fs13738-018-1433-9&partnerID=40&md5=5cc1c5bdf556de18241cd60c45f097c1

Similar Items

Synthesis, β-glucuronidase inhibition and molecular docking studies of cyano-substituted bisindole hydrazone hybrids
by: Abid O.; Imran S.; Taha M.; Ismail N.H.; Jamil W.; Kashif S.M.; Khan K.M.; Yusoff J.
Published: (2021)

Synthesis, β-glucuronidase inhibition and molecular docking studies of hybrid bisindole-thiosemicarbazides analogs
by: Taha M.; Ismail N.H.; Imran S.; Rahim F.; Wadood A.; Khan H.; Ullah H.; Salar U.; Khan K.M.
Published: (2016)

Synthesis of indole analogs as potent β-glucuronidase inhibitors
by: Baharudin M.S.; Taha M.; Imran S.; Ismail N.H.; Rahim F.; Javid M.T.; Khan K.M.; Ali M.
Published: (2017)

Identification of bisindolylmethane-hydrazone hybrids as novel inhibitors of β-glucuronidase, DFT, and in silico SAR intimations
by: Taha M.; Ismail N.H.; Imran S.; Anouar E.H.; Ali M.; Jamil W.; Uddin N.; Kashif S.M.
Published: (2016)

Synthesis: Small library of hybrid scaffolds of benzothiazole having hydrazone and evaluation of their β-glucuronidase activity
by: Taha M.; Arbin M.; Ahmat N.; Imran S.; Rahim F.
Published: (2018)

Phenoxyacetohydrazide schiff bases: β-glucuronidase inhibitors
by: Jamil W.; Perveen S.; Shah S.A.A.; Taha M.; Ismail N.H.; Perveen S.; Ambreen N.; Khan K.M.; Choudhary M.I.
Published: (2014)

Synthesis of bis-indolylmethanes as new potential inhibitors of β-glucuronidase and their molecular docking studies
by: Taha M.; Ullah H.; Al Muqarrabun L.M.R.; Khan M.N.; Rahim F.; Ahmat N.; Ali M.; Perveen S.
Published: (2018)

Synthesis and biological evaluation of heterocyclic 1,2,4-triazole scaffolds as promising pharmacological agents
by: Kumari M.; Tahlan S.; Narasimhan B.; Ramasamy K.; Lim S.M.; Shah S.A.A.; Mani V.; Kakkar S.
Published: (2021)

Synthesis and evaluation of unsymmetrical heterocyclic thioureas as potent β-glucuronidase inhibitors
by: Taha M.; Ismail N.H.; Jamil W.; Khan K.M.; Salar U.; Kashif S.M.; Rahim F.; Latif Y.
Published: (2015)

Dihydropyrimidones: As novel class of β-glucuronidase inhibitors
by: Ali F.; Khan K.M.; Salar U.; Iqbal S.; Taha M.; Ismail N.H.; Perveen S.; Wadood A.; Ghufran M.; Ali B.
Published: (2016)

Thiadiazole derivatives as New Class of β-glucuronidase inhibitors
by: Salar U.; Taha M.; Ismail N.H.; Khan K.M.; Imran S.; Perveen S.; Wadood A.; Riaz M.
Published: (2016)

Synthesis of 6-chloro-2-Aryl-1H-imidazo[4,5-b]pyridine derivatives: Antidiabetic, antioxidant, β-glucuronidase inhibiton and their molecular docking studies
by: Taha M.; Ismail N.H.; Imran S.; Rashwan H.; Jamil W.; Ali S.; Kashif S.M.; Rahim F.; Salar U.; Khan K.M.
Published: (2016)

Synthesis of novel inhibitors of β-glucuronidase based on the benzothiazole skeleton and their molecular docking studies
by: Taha M.; Ismail N.H.; Imran S.; Selvaraj M.; Rahim F.
Published: (2016)

Synthesis of novel flavone hydrazones: In-vitro evaluation of α-glucosidase inhibition, QSAR analysis and docking studies
by: Imran S.; Taha M.; Ismail N.H.; Kashif S.M.; Rahim F.; Jamil W.; Hariono M.; Yusuf M.; Wahab H.
Published: (2015)

Synthesis of novel benzohydrazone-oxadiazole hybrids as β-glucuronidase inhibitors and molecular modeling studies
by: Taha M.; Ismail N.H.; Imran S.; Selvaraj M.; Rahim A.; Ali M.; Siddiqui S.; Rahim F.; Khan K.M.
Published: (2015)

Evaluation of bisindole as potent β-glucuronidase inhibitors: Synthesis and in silico based studies
by: Khan K.M.; Rahim F.; Wadood A.; Taha M.; Khan M.; Naureen S.; Ambreen N.; Hussain S.; Perveen S.; Choudhary M.I.
Published: (2014)

New Cholinesterase inhibitors based on 1,2,4-triazole bearing benzenesulfonohydrazide skeleton: Synthesis, in vitro and in silico studies
by: Othman M.S.; Naz H.; Rahim F.; Ullah H.; Hussain R.; Taha M.; Khan S.; Fareid M.A.; Aboelnaga S.M.; Altaleb A.T.; Iqbal R.; Adnan Ali Shah S.
Published: (2024)

Synthesis of oxadiazole-coupled-thiadiazole derivatives as a potent β-glucuronidase inhibitors and their molecular docking study
by: Taha M.; Imran S.; Alomari M.; Rahim F.; Wadood A.; Mosaddik A.; Uddin N.; Gollapalli M.; Alqahtani M.A.; Bamarouf Y.A.
Published: (2019)

Synthesis and β-glucuronidase inhibitory activity of 2-arylquinazolin-4(3H)-ones
by: Khan K.M.; Saad S.M.; Shaikh N.N.; Hussain S.; Fakhri M.I.; Perveen S.; Taha M.; Choudhary M.I.
Published: (2014)

Discovery of Dual Inhibitors of Acetyl and Butrylcholinesterase and Antiproliferative Activity of 1,2,4-Triazole-3-thiol: Synthesis and In Silico Molecular Study
by: Siddiqui S.Z.; Arfan M.; Abbasi M.A.; Aziz-ur-Rehman; Shah S.A.A.; Ashraf M.; Hussain S.; Saleem R.S.Z.; Rafique R.; Khan K.M.
Published: (2020)

Bio-Oriented Synthesis and Molecular Docking Studies of 1,2,4-Triazole Based Derivatives as Potential Anti-Cancer Agents against HepG2 Cell Line
by: Akhter N.; Batool S.; Khan S.G.; Rasool N.; Anjum F.; Rasul A.; Adem Ş.; Mahmood S.; Rehman A.U.; Nisa M.U.; Razzaq Z.; Christensen J.B.; Abourehab M.A.S.; Shah S.A.A.; Imran S.
Published: (2023)

Synthesis of novel disulfide and sulfone hybrid scaffolds as potent β-glucuronidase inhibitor
by: Taha M.; Ismail N.H.; Imran S.; Wadood A.; Rahim F.; Al Muqarrabin L.M.R.; Zaki H.M.; Ahmat N.; Nasir A.; Khan F.
Published: (2016)

Insight parameter drug design for human β-tryptase inhibition integrated molecular docking, QSAR, molecular dynamics simulation, and pharmacophore modelling studies of α-keto-[1,2,4]-oxadiazoles
by: Yu C.X.; Tan J.W.; Rullah K.; Imran S.; Tham C.L.
Published: (2023)

Synthesis of modified Schiff base appended 1,2,4-triazole hybrids scaffolds: Elucidating the in vitro and in silico α-amylase and α-glucosidase inhibitors potential
by: Abbasi S.A.; Rahim F.; Hussain R.; Rehman W.; Khan S.; Taha M.; Iqbal T.; Khan Y.; Ali Shah S.A.
Published: (2024)

Synthesis of benzimidazole derivatives as potent β-glucuronidase inhibitors
by: Taha M.; Ismail N.H.; Imran S.; Selvaraj M.; Rashwan H.; Farhanah F.U.; Rahim F.; Kesavanarayanan K.S.; Ali M.
Published: (2015)

Novel 1,2,4-triazoles as anti-enzymatic agents: Microwave versus conventional synthesis, characterization, docking and BSA binding studies
by: Akhtar Virk N.; Rehman A.U.; Shuaib A.; Iqbal J.; Rasool S.; Al-Mijalli S.H.; Abid M.A.; Nisa M.-U.; Ali Shah S.A.; Saadiq M.
Published: (2023)

Conventional versus microwave assisted synthesis, molecular docking and enzyme inhibitory activities of new 3,4,5-trisubstituted-1,2,4-triazole analogues
by: Virk N.A.; Rehman A.; Abbasi M.A.; Siddiqui S.Z.; Rashid U.; Iqbal J.; Saleem M.; Ashraf M.; Shahid W.; Shah S.A.A.
Published: (2018)

Synthesis of modified Schiff base appended 1,2,4-triazole hybrids scaffolds: elucidating the in vitro and in silico α-amylase and α-glucosidase inhibitors potential
by: Abbasi, et al.
Published: (2024)

Synthesis of new 1,2-disubstituted benzimidazole analogs as potent inhibitors of β-Glucuronidase and in silico study
by: Taha M.; Ahmad Khan A.; Rahim F.; Imran S.; Salahuddin M.; Uddin N.; Mohammed Khan K.; Adnan Ali Shah S.; Zafar A.; Amiruddin Zakaria Z.
Published: (2022)

Synthesis of novel derivatives of oxindole, their urease inhibition and molecular docking studies
by: Taha M.; Ismail N.H.; Khan A.; Shah S.A.A.; Anwar A.; Halim S.A.; Fatmi M.Q.; Imran S.; Rahim F.; Khan K.M.
Published: (2015)

Design, synthesis of triazole-based scaffolds, N-(substitutedphenyl)-2-(5-(4-methoxyphenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthiol)acetamides: As potential anti-cholinesterase agents for neurodegenerative diseases
by: Siddiqui S.Z.; Arfan M.; Abbasi M.A.; Aziz-ur-Rehman; Shah S.A.A.; Parveen R.; Ashraf M.; Solangi M.; Hussain S.; Khan K.M.
Published: (2023)

Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivatives
by: Taha M.; Shah S.A.A.; Afifi M.; Imran S.; Sultan S.; Rahim F.; Khan K.M.
Published: (2018)

Synthesis of chromen-4-one-oxadiazole substituted analogs as potent β-glucuronidase inhibitors
by: Taha M.; Rahim F.; Ali M.; Khan M.N.; Alqahtani M.A.; Bamarouf Y.A.; Gollapalli M.; Farooq R.K.; Ali Shah S.A.; Ahmed Q.U.; Zakaria Z.A.
Published: (2019)

Morpholine hydrazone scaffold: Synthesis, anticancer activity and docking studies
by: Taha M.; Ali Shah S.A.; Afifi M.; Zulkeflee M.; Sultan S.; Wadood A.; Rahim F.; Ismail N.H.
Published: (2017)

The β-carboline analogs as a potent inhibitor for Alzheimer's Disease, molecular docking and dynamics simulation study
by: Taha M.; Rahim F.; Khan A.A.; Adalat B.; Imran S.; Alshehri J.M.; Ahmad A.; Khan K.M.; Shah S.A.A.; Uddin N.
Published: (2023)

Innovative cholinergic scaffolds, synthesis, and characterization of substituted 1,2,4-triazole-3-ylthio-N-acetamides and their in silico studies: supplement against neurodegenerative disease
by: Arfan M.; Siddiqui S.Z.; Abbasi M.A.; Aziz-ur-Rehman; Saad S.M.; Shah S.A.A.; Ashraf M.; Hussain S.; Ali F.; Solangi M.; Khan K.M.
Published: (2023)

Synthesis, in vitro β-glucuronidase inhibitory activity and in silico studies of novel (E)-4-Aryl-2-(2-(pyren-1-ylmethylene)hydrazinyl)thiazoles
by: Salar U.; Khan K.M.; Syed S.; Taha M.; Ali F.; Ismail N.H.; Perveen S.; Wadood A.; Ghufran M.
Published: (2017)

Synthesis of benzophenone hydrazone analogs and their DPPH radical scavenging and urease inhibitory activities
by: Khan K.M.; Rahim F.; Khan A.; Ali S.; Taha M.; Saad S.M.; Khan M.; Najeebullah; Shaikh A.; Perveen S.; Choudhary M.I.
Published: (2015)

Novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone: A new class of β-glucuronidase inhibitors and in silico studies
by: Zawawi N.K.N.A.; Taha M.; Ahmat N.; Wadood A.; Ismail N.H.; Rahim F.; Ali M.; Abdullah N.; Khan K.M.
Published: (2015)

Synthesis, crystal structure, photophysical properties, DFT studies and Hirshfeld surface analysis of a phosphorescent 1,2,4-triazole-based iridium(III) complex
by: Bain N.H.A.S.; Ali N.M.; Juahir Y.; Hashim N.; Isa I.M.; Mohamed A.; Kamari A.; Anouar E.H.; Yamin B.M.; Tajuddin A.M.; Baharudin M.H.
Published: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v2rq6fsrcqdo2aud4ld0gn3su4